The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global β-Lactamase Inhibitors API Market Research Report 2025

Global β-Lactamase Inhibitors API Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1926759

No of Pages : 92

Ask Your Query
Synopsis
β-Lactamase Inhibitors are a class of medicine that block the activity of beta-lactamase enzymes (also called beta-lactamases), preventing the degradation of beta-lactam antibiotics. They tend to have little antibiotic activity on their own. β-Lactamase Inhibitors APIs mainly include clavulanic acid, sulbactam, tazobactam, avibactam, relebactam, durlobactam, and vaborbactam.
The global β-Lactamase Inhibitors API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for β-Lactamase Inhibitors API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for β-Lactamase Inhibitors API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of β-Lactamase Inhibitors API include GSK, Medopharm, Cayman Chemical, ACS Dobfar SpA, Kyongbo Pharmaceutical, Rajasthan Antibiotics Ltd., Jiangxi Fushine Pharmaceutical, China Pharmaceutical Group and Jingjing Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for β-Lactamase Inhibitors API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding β-Lactamase Inhibitors API.
Report Scope
The β-Lactamase Inhibitors API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global β-Lactamase Inhibitors API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the β-Lactamase Inhibitors API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Medopharm
Cayman Chemical
ACS Dobfar SpA
Kyongbo Pharmaceutical
Rajasthan Antibiotics Ltd.
Jiangxi Fushine Pharmaceutical
China Pharmaceutical Group
Jingjing Pharmaceutical
Shandong New Time Pharmaceutical
Zhuhai United Laboratories
Henan Kangda Pharmaceutical
Zhejiang Huabang Medical&Chemical
Segment by Type
Clavulanic Acid
Sulbactam
Tazobactam
Avibactam
Others
Segment by Application
Injections
Oral Preparations
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of β-Lactamase Inhibitors API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of β-Lactamase Inhibitors API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 β-Lactamase Inhibitors API Market Overview
1.1 Product Overview and Scope of β-Lactamase Inhibitors API
1.2 β-Lactamase Inhibitors API Segment by Type
1.2.1 Global β-Lactamase Inhibitors API Market Value Comparison by Type (2024-2030)
1.2.2 Clavulanic Acid
1.2.3 Sulbactam
1.2.4 Tazobactam
1.2.5 Avibactam
1.2.6 Others
1.3 β-Lactamase Inhibitors API Segment by Application
1.3.1 Global β-Lactamase Inhibitors API Market Value by Application: (2024-2030)
1.3.2 Injections
1.3.3 Oral Preparations
1.4 Global β-Lactamase Inhibitors API Market Size Estimates and Forecasts
1.4.1 Global β-Lactamase Inhibitors API Revenue 2019-2030
1.4.2 Global β-Lactamase Inhibitors API Sales 2019-2030
1.4.3 Global β-Lactamase Inhibitors API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 β-Lactamase Inhibitors API Market Competition by Manufacturers
2.1 Global β-Lactamase Inhibitors API Sales Market Share by Manufacturers (2019-2024)
2.2 Global β-Lactamase Inhibitors API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global β-Lactamase Inhibitors API Average Price by Manufacturers (2019-2024)
2.4 Global β-Lactamase Inhibitors API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of β-Lactamase Inhibitors API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of β-Lactamase Inhibitors API, Product Type & Application
2.7 β-Lactamase Inhibitors API Market Competitive Situation and Trends
2.7.1 β-Lactamase Inhibitors API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest β-Lactamase Inhibitors API Players Market Share by Revenue
2.7.3 Global β-Lactamase Inhibitors API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 β-Lactamase Inhibitors API Retrospective Market Scenario by Region
3.1 Global β-Lactamase Inhibitors API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global β-Lactamase Inhibitors API Global β-Lactamase Inhibitors API Sales by Region: 2019-2030
3.2.1 Global β-Lactamase Inhibitors API Sales by Region: 2019-2024
3.2.2 Global β-Lactamase Inhibitors API Sales by Region: 2025-2030
3.3 Global β-Lactamase Inhibitors API Global β-Lactamase Inhibitors API Revenue by Region: 2019-2030
3.3.1 Global β-Lactamase Inhibitors API Revenue by Region: 2019-2024
3.3.2 Global β-Lactamase Inhibitors API Revenue by Region: 2025-2030
3.4 North America β-Lactamase Inhibitors API Market Facts & Figures by Country
3.4.1 North America β-Lactamase Inhibitors API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America β-Lactamase Inhibitors API Sales by Country (2019-2030)
3.4.3 North America β-Lactamase Inhibitors API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe β-Lactamase Inhibitors API Market Facts & Figures by Country
3.5.1 Europe β-Lactamase Inhibitors API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe β-Lactamase Inhibitors API Sales by Country (2019-2030)
3.5.3 Europe β-Lactamase Inhibitors API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific β-Lactamase Inhibitors API Market Facts & Figures by Country
3.6.1 Asia Pacific β-Lactamase Inhibitors API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific β-Lactamase Inhibitors API Sales by Country (2019-2030)
3.6.3 Asia Pacific β-Lactamase Inhibitors API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America β-Lactamase Inhibitors API Market Facts & Figures by Country
3.7.1 Latin America β-Lactamase Inhibitors API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America β-Lactamase Inhibitors API Sales by Country (2019-2030)
3.7.3 Latin America β-Lactamase Inhibitors API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa β-Lactamase Inhibitors API Market Facts & Figures by Country
3.8.1 Middle East and Africa β-Lactamase Inhibitors API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa β-Lactamase Inhibitors API Sales by Country (2019-2030)
3.8.3 Middle East and Africa β-Lactamase Inhibitors API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global β-Lactamase Inhibitors API Sales by Type (2019-2030)
4.1.1 Global β-Lactamase Inhibitors API Sales by Type (2019-2024)
4.1.2 Global β-Lactamase Inhibitors API Sales by Type (2025-2030)
4.1.3 Global β-Lactamase Inhibitors API Sales Market Share by Type (2019-2030)
4.2 Global β-Lactamase Inhibitors API Revenue by Type (2019-2030)
4.2.1 Global β-Lactamase Inhibitors API Revenue by Type (2019-2024)
4.2.2 Global β-Lactamase Inhibitors API Revenue by Type (2025-2030)
4.2.3 Global β-Lactamase Inhibitors API Revenue Market Share by Type (2019-2030)
4.3 Global β-Lactamase Inhibitors API Price by Type (2019-2030)
5 Segment by Application
5.1 Global β-Lactamase Inhibitors API Sales by Application (2019-2030)
5.1.1 Global β-Lactamase Inhibitors API Sales by Application (2019-2024)
5.1.2 Global β-Lactamase Inhibitors API Sales by Application (2025-2030)
5.1.3 Global β-Lactamase Inhibitors API Sales Market Share by Application (2019-2030)
5.2 Global β-Lactamase Inhibitors API Revenue by Application (2019-2030)
5.2.1 Global β-Lactamase Inhibitors API Revenue by Application (2019-2024)
5.2.2 Global β-Lactamase Inhibitors API Revenue by Application (2025-2030)
5.2.3 Global β-Lactamase Inhibitors API Revenue Market Share by Application (2019-2030)
5.3 Global β-Lactamase Inhibitors API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK β-Lactamase Inhibitors API Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Medopharm
6.2.1 Medopharm Corporation Information
6.2.2 Medopharm Description and Business Overview
6.2.3 Medopharm β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medopharm β-Lactamase Inhibitors API Product Portfolio
6.2.5 Medopharm Recent Developments/Updates
6.3 Cayman Chemical
6.3.1 Cayman Chemical Corporation Information
6.3.2 Cayman Chemical Description and Business Overview
6.3.3 Cayman Chemical β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cayman Chemical β-Lactamase Inhibitors API Product Portfolio
6.3.5 Cayman Chemical Recent Developments/Updates
6.4 ACS Dobfar SpA
6.4.1 ACS Dobfar SpA Corporation Information
6.4.2 ACS Dobfar SpA Description and Business Overview
6.4.3 ACS Dobfar SpA β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ACS Dobfar SpA β-Lactamase Inhibitors API Product Portfolio
6.4.5 ACS Dobfar SpA Recent Developments/Updates
6.5 Kyongbo Pharmaceutical
6.5.1 Kyongbo Pharmaceutical Corporation Information
6.5.2 Kyongbo Pharmaceutical Description and Business Overview
6.5.3 Kyongbo Pharmaceutical β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kyongbo Pharmaceutical β-Lactamase Inhibitors API Product Portfolio
6.5.5 Kyongbo Pharmaceutical Recent Developments/Updates
6.6 Rajasthan Antibiotics Ltd.
6.6.1 Rajasthan Antibiotics Ltd. Corporation Information
6.6.2 Rajasthan Antibiotics Ltd. Description and Business Overview
6.6.3 Rajasthan Antibiotics Ltd. β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Rajasthan Antibiotics Ltd. β-Lactamase Inhibitors API Product Portfolio
6.6.5 Rajasthan Antibiotics Ltd. Recent Developments/Updates
6.7 Jiangxi Fushine Pharmaceutical
6.6.1 Jiangxi Fushine Pharmaceutical Corporation Information
6.6.2 Jiangxi Fushine Pharmaceutical Description and Business Overview
6.6.3 Jiangxi Fushine Pharmaceutical β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangxi Fushine Pharmaceutical β-Lactamase Inhibitors API Product Portfolio
6.7.5 Jiangxi Fushine Pharmaceutical Recent Developments/Updates
6.8 China Pharmaceutical Group
6.8.1 China Pharmaceutical Group Corporation Information
6.8.2 China Pharmaceutical Group Description and Business Overview
6.8.3 China Pharmaceutical Group β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 China Pharmaceutical Group β-Lactamase Inhibitors API Product Portfolio
6.8.5 China Pharmaceutical Group Recent Developments/Updates
6.9 Jingjing Pharmaceutical
6.9.1 Jingjing Pharmaceutical Corporation Information
6.9.2 Jingjing Pharmaceutical Description and Business Overview
6.9.3 Jingjing Pharmaceutical β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jingjing Pharmaceutical β-Lactamase Inhibitors API Product Portfolio
6.9.5 Jingjing Pharmaceutical Recent Developments/Updates
6.10 Shandong New Time Pharmaceutical
6.10.1 Shandong New Time Pharmaceutical Corporation Information
6.10.2 Shandong New Time Pharmaceutical Description and Business Overview
6.10.3 Shandong New Time Pharmaceutical β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shandong New Time Pharmaceutical β-Lactamase Inhibitors API Product Portfolio
6.10.5 Shandong New Time Pharmaceutical Recent Developments/Updates
6.11 Zhuhai United Laboratories
6.11.1 Zhuhai United Laboratories Corporation Information
6.11.2 Zhuhai United Laboratories β-Lactamase Inhibitors API Description and Business Overview
6.11.3 Zhuhai United Laboratories β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhuhai United Laboratories β-Lactamase Inhibitors API Product Portfolio
6.11.5 Zhuhai United Laboratories Recent Developments/Updates
6.12 Henan Kangda Pharmaceutical
6.12.1 Henan Kangda Pharmaceutical Corporation Information
6.12.2 Henan Kangda Pharmaceutical β-Lactamase Inhibitors API Description and Business Overview
6.12.3 Henan Kangda Pharmaceutical β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Henan Kangda Pharmaceutical β-Lactamase Inhibitors API Product Portfolio
6.12.5 Henan Kangda Pharmaceutical Recent Developments/Updates
6.13 Zhejiang Huabang Medical&Chemical
6.13.1 Zhejiang Huabang Medical&Chemical Corporation Information
6.13.2 Zhejiang Huabang Medical&Chemical β-Lactamase Inhibitors API Description and Business Overview
6.13.3 Zhejiang Huabang Medical&Chemical β-Lactamase Inhibitors API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zhejiang Huabang Medical&Chemical β-Lactamase Inhibitors API Product Portfolio
6.13.5 Zhejiang Huabang Medical&Chemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 β-Lactamase Inhibitors API Industry Chain Analysis
7.2 β-Lactamase Inhibitors API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 β-Lactamase Inhibitors API Production Mode & Process
7.4 β-Lactamase Inhibitors API Sales and Marketing
7.4.1 β-Lactamase Inhibitors API Sales Channels
7.4.2 β-Lactamase Inhibitors API Distributors
7.5 β-Lactamase Inhibitors API Customers
8 β-Lactamase Inhibitors API Market Dynamics
8.1 β-Lactamase Inhibitors API Industry Trends
8.2 β-Lactamase Inhibitors API Market Drivers
8.3 β-Lactamase Inhibitors API Market Challenges
8.4 β-Lactamase Inhibitors API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global β-Lactamase Inhibitors API Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global β-Lactamase Inhibitors API Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global β-Lactamase Inhibitors API Market Competitive Situation by Manufacturers in 2023
Table 4. Global β-Lactamase Inhibitors API Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global β-Lactamase Inhibitors API Sales Market Share by Manufacturers (2019-2024)
Table 6. Global β-Lactamase Inhibitors API Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global β-Lactamase Inhibitors API Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market β-Lactamase Inhibitors API Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of β-Lactamase Inhibitors API, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of β-Lactamase Inhibitors API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of β-Lactamase Inhibitors API, Product Type & Application
Table 12. Global Key Manufacturers of β-Lactamase Inhibitors API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global β-Lactamase Inhibitors API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β-Lactamase Inhibitors API as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global β-Lactamase Inhibitors API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global β-Lactamase Inhibitors API Sales by Region (2019-2024) & (Tons)
Table 18. Global β-Lactamase Inhibitors API Sales Market Share by Region (2019-2024)
Table 19. Global β-Lactamase Inhibitors API Sales by Region (2025-2030) & (Tons)
Table 20. Global β-Lactamase Inhibitors API Sales Market Share by Region (2025-2030)
Table 21. Global β-Lactamase Inhibitors API Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global β-Lactamase Inhibitors API Revenue Market Share by Region (2019-2024)
Table 23. Global β-Lactamase Inhibitors API Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global β-Lactamase Inhibitors API Revenue Market Share by Region (2025-2030)
Table 25. North America β-Lactamase Inhibitors API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America β-Lactamase Inhibitors API Sales by Country (2019-2024) & (Tons)
Table 27. North America β-Lactamase Inhibitors API Sales by Country (2025-2030) & (Tons)
Table 28. North America β-Lactamase Inhibitors API Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America β-Lactamase Inhibitors API Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe β-Lactamase Inhibitors API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe β-Lactamase Inhibitors API Sales by Country (2019-2024) & (Tons)
Table 32. Europe β-Lactamase Inhibitors API Sales by Country (2025-2030) & (Tons)
Table 33. Europe β-Lactamase Inhibitors API Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe β-Lactamase Inhibitors API Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific β-Lactamase Inhibitors API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific β-Lactamase Inhibitors API Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific β-Lactamase Inhibitors API Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific β-Lactamase Inhibitors API Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific β-Lactamase Inhibitors API Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America β-Lactamase Inhibitors API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America β-Lactamase Inhibitors API Sales by Country (2019-2024) & (Tons)
Table 42. Latin America β-Lactamase Inhibitors API Sales by Country (2025-2030) & (Tons)
Table 43. Latin America β-Lactamase Inhibitors API Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America β-Lactamase Inhibitors API Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa β-Lactamase Inhibitors API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa β-Lactamase Inhibitors API Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa β-Lactamase Inhibitors API Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa β-Lactamase Inhibitors API Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa β-Lactamase Inhibitors API Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global β-Lactamase Inhibitors API Sales (Tons) by Type (2019-2024)
Table 51. Global β-Lactamase Inhibitors API Sales (Tons) by Type (2025-2030)
Table 52. Global β-Lactamase Inhibitors API Sales Market Share by Type (2019-2024)
Table 53. Global β-Lactamase Inhibitors API Sales Market Share by Type (2025-2030)
Table 54. Global β-Lactamase Inhibitors API Revenue (US$ Million) by Type (2019-2024)
Table 55. Global β-Lactamase Inhibitors API Revenue (US$ Million) by Type (2025-2030)
Table 56. Global β-Lactamase Inhibitors API Revenue Market Share by Type (2019-2024)
Table 57. Global β-Lactamase Inhibitors API Revenue Market Share by Type (2025-2030)
Table 58. Global β-Lactamase Inhibitors API Price (US$/Kg) by Type (2019-2024)
Table 59. Global β-Lactamase Inhibitors API Price (US$/Kg) by Type (2025-2030)
Table 60. Global β-Lactamase Inhibitors API Sales (Tons) by Application (2019-2024)
Table 61. Global β-Lactamase Inhibitors API Sales (Tons) by Application (2025-2030)
Table 62. Global β-Lactamase Inhibitors API Sales Market Share by Application (2019-2024)
Table 63. Global β-Lactamase Inhibitors API Sales Market Share by Application (2025-2030)
Table 64. Global β-Lactamase Inhibitors API Revenue (US$ Million) by Application (2019-2024)
Table 65. Global β-Lactamase Inhibitors API Revenue (US$ Million) by Application (2025-2030)
Table 66. Global β-Lactamase Inhibitors API Revenue Market Share by Application (2019-2024)
Table 67. Global β-Lactamase Inhibitors API Revenue Market Share by Application (2025-2030)
Table 68. Global β-Lactamase Inhibitors API Price (US$/Kg) by Application (2019-2024)
Table 69. Global β-Lactamase Inhibitors API Price (US$/Kg) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. GSK β-Lactamase Inhibitors API Product
Table 74. GSK Recent Developments/Updates
Table 75. Medopharm Corporation Information
Table 76. Medopharm Description and Business Overview
Table 77. Medopharm β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Medopharm β-Lactamase Inhibitors API Product
Table 79. Medopharm Recent Developments/Updates
Table 80. Cayman Chemical Corporation Information
Table 81. Cayman Chemical Description and Business Overview
Table 82. Cayman Chemical β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Cayman Chemical β-Lactamase Inhibitors API Product
Table 84. Cayman Chemical Recent Developments/Updates
Table 85. ACS Dobfar SpA Corporation Information
Table 86. ACS Dobfar SpA Description and Business Overview
Table 87. ACS Dobfar SpA β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. ACS Dobfar SpA β-Lactamase Inhibitors API Product
Table 89. ACS Dobfar SpA Recent Developments/Updates
Table 90. Kyongbo Pharmaceutical Corporation Information
Table 91. Kyongbo Pharmaceutical Description and Business Overview
Table 92. Kyongbo Pharmaceutical β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Kyongbo Pharmaceutical β-Lactamase Inhibitors API Product
Table 94. Kyongbo Pharmaceutical Recent Developments/Updates
Table 95. Rajasthan Antibiotics Ltd. Corporation Information
Table 96. Rajasthan Antibiotics Ltd. Description and Business Overview
Table 97. Rajasthan Antibiotics Ltd. β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Rajasthan Antibiotics Ltd. β-Lactamase Inhibitors API Product
Table 99. Rajasthan Antibiotics Ltd. Recent Developments/Updates
Table 100. Jiangxi Fushine Pharmaceutical Corporation Information
Table 101. Jiangxi Fushine Pharmaceutical Description and Business Overview
Table 102. Jiangxi Fushine Pharmaceutical β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Jiangxi Fushine Pharmaceutical β-Lactamase Inhibitors API Product
Table 104. Jiangxi Fushine Pharmaceutical Recent Developments/Updates
Table 105. China Pharmaceutical Group Corporation Information
Table 106. China Pharmaceutical Group Description and Business Overview
Table 107. China Pharmaceutical Group β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. China Pharmaceutical Group β-Lactamase Inhibitors API Product
Table 109. China Pharmaceutical Group Recent Developments/Updates
Table 110. Jingjing Pharmaceutical Corporation Information
Table 111. Jingjing Pharmaceutical Description and Business Overview
Table 112. Jingjing Pharmaceutical β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Jingjing Pharmaceutical β-Lactamase Inhibitors API Product
Table 114. Jingjing Pharmaceutical Recent Developments/Updates
Table 115. Shandong New Time Pharmaceutical Corporation Information
Table 116. Shandong New Time Pharmaceutical Description and Business Overview
Table 117. Shandong New Time Pharmaceutical β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Shandong New Time Pharmaceutical β-Lactamase Inhibitors API Product
Table 119. Shandong New Time Pharmaceutical Recent Developments/Updates
Table 120. Zhuhai United Laboratories Corporation Information
Table 121. Zhuhai United Laboratories Description and Business Overview
Table 122. Zhuhai United Laboratories β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Zhuhai United Laboratories β-Lactamase Inhibitors API Product
Table 124. Zhuhai United Laboratories Recent Developments/Updates
Table 125. Henan Kangda Pharmaceutical Corporation Information
Table 126. Henan Kangda Pharmaceutical Description and Business Overview
Table 127. Henan Kangda Pharmaceutical β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Henan Kangda Pharmaceutical β-Lactamase Inhibitors API Product
Table 129. Henan Kangda Pharmaceutical Recent Developments/Updates
Table 130. Zhejiang Huabang Medical&Chemical Corporation Information
Table 131. Zhejiang Huabang Medical&Chemical Description and Business Overview
Table 132. Zhejiang Huabang Medical&Chemical β-Lactamase Inhibitors API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Zhejiang Huabang Medical&Chemical β-Lactamase Inhibitors API Product
Table 134. Zhejiang Huabang Medical&Chemical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. β-Lactamase Inhibitors API Distributors List
Table 138. β-Lactamase Inhibitors API Customers List
Table 139. β-Lactamase Inhibitors API Market Trends
Table 140. β-Lactamase Inhibitors API Market Drivers
Table 141. β-Lactamase Inhibitors API Market Challenges
Table 142. β-Lactamase Inhibitors API Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of β-Lactamase Inhibitors API
Figure 2. Global β-Lactamase Inhibitors API Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global β-Lactamase Inhibitors API Market Share by Type in 2023 & 2030
Figure 4. Clavulanic Acid Product Picture
Figure 5. Sulbactam Product Picture
Figure 6. Tazobactam Product Picture
Figure 7. Avibactam Product Picture
Figure 8. Others Product Picture
Figure 9. Global β-Lactamase Inhibitors API Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global β-Lactamase Inhibitors API Market Share by Application in 2023 & 2030
Figure 11. Injections
Figure 12. Oral Preparations
Figure 13. Global β-Lactamase Inhibitors API Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global β-Lactamase Inhibitors API Market Size (2019-2030) & (US$ Million)
Figure 15. Global β-Lactamase Inhibitors API Sales (2019-2030) & (Tons)
Figure 16. Global β-Lactamase Inhibitors API Average Price (US$/Kg) & (2019-2030)
Figure 17. β-Lactamase Inhibitors API Report Years Considered
Figure 18. β-Lactamase Inhibitors API Sales Share by Manufacturers in 2023
Figure 19. Global β-Lactamase Inhibitors API Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest β-Lactamase Inhibitors API Players: Market Share by Revenue in 2023
Figure 21. β-Lactamase Inhibitors API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global β-Lactamase Inhibitors API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America β-Lactamase Inhibitors API Sales Market Share by Country (2019-2030)
Figure 24. North America β-Lactamase Inhibitors API Revenue Market Share by Country (2019-2030)
Figure 25. United States β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe β-Lactamase Inhibitors API Sales Market Share by Country (2019-2030)
Figure 28. Europe β-Lactamase Inhibitors API Revenue Market Share by Country (2019-2030)
Figure 29. Germany β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Netherlands β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific β-Lactamase Inhibitors API Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific β-Lactamase Inhibitors API Revenue Market Share by Region (2019-2030)
Figure 36. China β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America β-Lactamase Inhibitors API Sales Market Share by Country (2019-2030)
Figure 44. Latin America β-Lactamase Inhibitors API Revenue Market Share by Country (2019-2030)
Figure 45. Mexico β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa β-Lactamase Inhibitors API Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa β-Lactamase Inhibitors API Revenue Market Share by Country (2019-2030)
Figure 51. Turkey β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE β-Lactamase Inhibitors API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of β-Lactamase Inhibitors API by Type (2019-2030)
Figure 55. Global Revenue Market Share of β-Lactamase Inhibitors API by Type (2019-2030)
Figure 56. Global β-Lactamase Inhibitors API Price (US$/Kg) by Type (2019-2030)
Figure 57. Global Sales Market Share of β-Lactamase Inhibitors API by Application (2019-2030)
Figure 58. Global Revenue Market Share of β-Lactamase Inhibitors API by Application (2019-2030)
Figure 59. Global β-Lactamase Inhibitors API Price (US$/Kg) by Application (2019-2030)
Figure 60. β-Lactamase Inhibitors API Value Chain
Figure 61. β-Lactamase Inhibitors API Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock